Black checkmark with a sparkle and a curved line underneath on a white background.
Company

TRANSCAT INC

Ticker
TRNS
Sector
Industry
Report date
November 3, 2026
Valye AI Score

93

Very high visibility
Recent developments
Recent developments summary

Recent news highlights Transcat's fiscal Q2 2027 revenue of $97.1 million and earnings performance exceeding estimates, alongside ongoing operational and talent development initiatives.

Recent developments:
  • Transcat reported fiscal second quarter 2027 total revenue of $97.1 million, reflecting ongoing business activity in its Service and Distribution segments [N1].
  • Q2 2027 earnings and revenues topped estimates, indicating operational execution aligned with company strategy [N3].
  • The company’s Q2 earnings metrics were analyzed in detail, highlighting key financial performance aspects [N2].
  • Discussions around maintaining an earnings surprise streak suggest consistent financial results [N4].
  • Transcat’s Q1 2027 earnings call transcript and highlights provide insights into recent operational and financial developments [N6][N7].
  • Q1 2027 earnings and revenues also topped estimates, supporting the narrative of steady performance [N8].
Overview

Transcat, Inc. provides accredited calibration, reliability, maintenance optimization, quality and compliance, validation, CMMS, and pipette services to regulated industries including life sciences, aerospace, defense, and energy. The company operates two complementary segments: Service and Distribution. The Service segment delivers calibration and related services through a network of ISO-accredited calibration centers and proprietary asset management software, serving over 27,000 customers. The Distribution segment markets and rents a broad range of test and measurement instruments from numerous brands. Transcat pursues growth through organic expansion and acquisitions, recently acquiring several calibration service providers to enhance geographic presence and capabilities. The company emphasizes quality, technical expertise, and customer service as competitive differentiators. Financial data from Q2 FY2027 shows revenue of $97.09 million and net income of $2.413 million, with liquidity ratios indicating solid short-term financial health.

Executive summary

Transcat, Inc. is a provider of accredited calibration and related services primarily to highly regulated industries such as life sciences, aerospace, and energy. The company operates through Service and Distribution segments, offering calibration, repair, and test instrument sales and rentals. Recent SEC filings detail a strategy focused on organic growth and acquisitions, with multiple recent acquisitions expanding geographic reach and capabilities. Financial data as of Q2 FY2027 shows revenue of $97.09 million and net income of $2.413 million. Liquidity ratios indicate a current ratio of 2.57 and cash ratio of 0.15. Recent news reports confirm Q2 2027 revenue and earnings performance and highlight ongoing operational initiatives and talent development programs. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for TRNS

Bull case model:

Transcat's integrated Service and Distribution segments provide a broad value proposition to customers in regulated industries, supported by proprietary technology and accredited quality systems. The company's acquisition strategy has expanded its geographic reach and service capabilities, enhancing market presence. Operational initiatives aimed at improving productivity and customer experience contribute to differentiation. The recurring nature of calibration services and the company's presence in multiple regulated sectors support revenue stability and diversification.

Bear case model:

Transcat operates in competitive markets where price pressures and regulatory changes could impact demand for calibration and distribution services. The reliance on subcontractors for specialized calibrations introduces operational complexity. Integration risks exist with recent acquisitions, and failure to realize synergies could affect financial performance. The Distribution segment faces competition from other equipment providers, and economic downturns in key industries could reduce capital spending on test and measurement equipment. Customer concentration risk is low but losing key customers could still impact results.

Moat:

Transcat's competitive advantages stem from its comprehensive and accredited calibration services, proprietary asset management systems (CalTrak® and C3®), and a broad distribution network offering over 75,000 instruments. Its focus on highly regulated industries requiring precise measurement and compliance creates high barriers to entry. The company's multi-segment approach enables cross-selling and diversified revenue streams. Additionally, its Operational Excellence initiative and talent development programs support sustained service quality and operational efficiency. The company's acquisition strategy further strengthens its geographic footprint and technical capabilities, reinforcing its market position.

Risks overview
Risks summary
The primary risks for Transcat relate to regulatory compliance, acquisition integration, competitive pressures, operational complexity, and economic sensitivity impacting demand.
Risks details:

• Regulatory and Compliance Risks: Transcat serves highly regulated industries where changes in regulations or failure to maintain accreditations could adversely affect business operations and customer relationships.
• Acquisition Integration Risks: The company’s growth strategy includes acquisitions that carry risks related to integration, realization of synergies, and potential disruption to operations.
• Market Competition and Pricing Pressure: Competition in calibration services and equipment distribution may lead to pricing pressures, impacting margins and profitability.
• Operational Complexity: Managing a large network of service centers and subcontractors for specialized calibrations introduces operational risks and potential quality control challenges.
• Economic Sensitivity: Demand for test and measurement equipment and calibration services may be sensitive to economic cycles affecting capital expenditures in key customer industries.

FINAL FORECAST FOR TRNS

Final take one line
Transcat, Inc. demonstrates very high visibility through detailed SEC disclosures and extensive recent news coverage highlighting its calibration and distribution services in regulated industries.
Final take 12 to 24 month view

Business trends: Continued focus on organic growth and acquisitions to expand calibration and distribution services in regulated industries.
Execution milestones: Integration of recent acquisitions, operational excellence initiatives, and talent development programs.
Key risks: Regulatory compliance challenges, acquisition integration risks, competitive pressures, operational complexity, and economic sensitivity.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

93
LLM visibility overview
LLM Visibility known facts
  • Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, CMMS, and pipette services.
  • The company serves highly regulated industries including life sciences (pharmaceutical, biotechnology, medical devices), aerospace and defense, and energy and utilities.
  • Transcat operates through two segments: Service and Distribution.
  • The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and related services, processed through proprietary asset management system CalTrak® and online portal C3®.
  • As of fiscal year 2026, Transcat operated 33 calibration service centers across the US, Canada, Ireland, and Costa Rica, all ISO/IEC 17025:2017 accredited.
  • The Service segment performs over 1.2 million calibrations annually, with approximately 13-15% subcontracted to third parties for specialized disciplines.
  • Transcat Solutions provides asset management services to the biopharmaceutical industry through six service tracks including calibration, maintenance, reliability, CMMS, quality and compliance, and validation.
  • The Distribution segment sells and rents over 75,000 test, measurement, and control instruments from approximately 400 brands globally, including new, used, and rental equipment.
  • The company emphasizes cross-selling between Service and Distribution segments to increase revenue.
  • Recent acquisitions include Essco Calibration Laboratory (2025), Martin Calibration (2024), Becnel Rental Tools (2024), and SCM Metrology and Laboratories in Costa Rica (2026), targeting geographic expansion, capability enhancement, and infrastructure leverage.
  • Transcat's strategy focuses on organic growth and acquisitions, with the Service segment expected to be the primary source of revenue and earnings growth due to higher margins and recurring revenue.
  • The company serves approximately 27,000 customers, with no single customer accounting for 3% or more of total revenue.
  • Financial snapshot as of September 26, 2026 (Q2 FY2027): total revenue $97.09 million, net income $2.413 million, basic EPS $0.26, diluted EPS $0.25.
  • Liquidity ratios as of September 26, 2026: current ratio 2.57, cash ratio 0.15, cash and equivalents $5.758 million, current assets $99.881 million, current liabilities $38.895 million.
  • Recent news highlights include fiscal Q2 2027 revenue of $97.1 million and earnings and revenues topping estimates for Q2 2027.
  • The company has ongoing initiatives such as Operational Excellence to improve productivity, efficiency, and customer experience.
  • Transcat University’s 'build-a-tech' program focuses on talent attraction and employee training.
  • The company emphasizes quality, integrity, and technical expertise as key competitive advantages.
  • Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Sources
Sources - Context summary

Generated 2026-11-04

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-05-27 | 10-K
  • S2 | 2026-11-03 | 10-Q
Sources - News headlines
  • N1 | 2026-11-04 | www.nasdaq.com | Transcat, Inc. Reports Fiscal Second Quarter 2027 Total Revenue of $97.1 Million | https://www.nasdaq.com/articles/transcat-inc-reports-fiscal-second-quarter-2027-total-revenue-971-million
  • N2 | 2026-11-03 | www.nasdaq.com | Transcat (TRNS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates | https://www.nasdaq.com/articles/transcat-trns-q2-earnings-taking-look-key-metrics-versus-estimates
  • N3 | 2026-11-03 | www.nasdaq.com | Transcat, Inc. (TRNS) Q2 Earnings and Revenues Top Estimates | https://www.nasdaq.com/articles/transcat-inc-trns-q2-earnings-and-revenues-top-estimates
  • N4 | 2026-10-29 | www.nasdaq.com | Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive? | https://www.nasdaq.com/articles/can-transcat-trns-keep-earnings-surprise-streak-alive
  • N5 | 2026-10-27 | www.nasdaq.com | Sensata (ST) Beats Q3 Earnings and Revenue Estimates | https://www.nasdaq.com/articles/sensata-st-beats-q3-earnings-and-revenue-estimates
  • N6 | 2026-08-12 | www.nasdaq.com | Transcat (TRNS) Q1 2027 Earnings Call Transcript | https://www.nasdaq.com/articles/transcat-trns-q1-2027-earnings-call-transcript
  • N7 | 2026-08-05 | www.nasdaq.com | Transcat Q1 Earnings Call Highlights | https://www.nasdaq.com/articles/transcat-q1-earnings-call-highlights
  • N8 | 2026-08-04 | www.nasdaq.com | Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates | https://www.nasdaq.com/articles/transcat-inc-trns-q1-earnings-and-revenues-top-estimates
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine